Jie Zhang
Kunming University of Science and Technology(CN)Zhejiang Chinese Medical University(CN)Qinghai University(CN)Fujian Medical University(CN)Anhui University(CN)China Pharmaceutical University(CN)Xuzhou Medical College(CN)Shanghai Jiao Tong University(CN)Yunnan University(CN)Anhui Medical University(CN)Nantong University(CN)Ningxia University(CN)Renji Hospital(CN)Soochow University(CN)Affiliated Hospital of Nantong University(CN)First People's Hospital of Yunnan Province(CN)Third People's Hospital of Chengdu(CN)Shanghai University of Traditional Chinese Medicine(CN)Longhua Hospital Shanghai University of Traditional Chinese Medicine(CN)Zhuhai People's Hospital(CN)Nantong Tumor Hospital(CN)Beijing Luhe Hospital Affiliated to Capital Medical University(CN)Second Affiliated Hospital of Soochow University(CN)Second People’s Hospital of Huai’an(CN)Qidong Liver Cancer Prevention Research(CN)First Affiliated Hospital of Bengbu Medical College(CN)Jiangsu Province Hospital(CN)Heilongjiang Vocational College of Art(CN)Heilongjiang Institute of Technology(CN)Taizhou Vocational and Technical College(CN)Xi’an Jiaotong-Liverpool University(CN)Taizhou University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, RNA modifications and cancer, Gut microbiota and health
Most-Cited Works
- → Functions of Shp2 in cancer(2015)250 cited
- → Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury(2014)147 cited
- → Video-assisted thoracoscopic solitary pulmonary nodule resection after CT-guided hookwire localization: 43 cases report and literature review(2010)141 cited
- → Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo(2004)139 cited
- → Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo(2018)137 cited
- → Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)(2020)116 cited